P512 Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis

D Pugliese,A Armuzzi,E Stasi,M Mendolaro,M Daperno,G Bodini,A C Privitera,D G Ribaldone,D Simondi,C Ricci,M L Scribano,M Principi,R D'Incà,S Saibeni

doi:10.1093/ecco-jcc/jjy222.636

P512 Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis

D Pugliese, A Armuzzi + Show 12 more

Open Access

https://doi.org/10.1093/ecco-jcc/jjy222.636

Copy DOI

Journal: Journal of Crohn's and Colitis

Publication Date: Jan 25, 2019

Affiliation: Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, Gastroenterology Hospital "Saverio de Bellis", A. O. Ordine Mauriziano di Torino, University of Genoa, Ospedale Cannizzaro, Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo, Spedali Civili di Brescia, University of Bari Aldo Moro, Polytechnic University of Bari, University of Padua, CTO Hospital

#ADAlimumab In Ulcerative Colitis #Practice In Italy + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

P512 Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Crohn's and Colitis

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.